Latest Biotechnology, Pharmaceutical and Healthcare News from PMLIVE

05:19 EST 23rd January 2018 | BioPortfolio

Here are the most relevant search results for "PMLIVE" found in our extensive news archives from over 250 global news sources.

More Information about PMLIVE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PMLIVE for you to read. Along with our medical data and news we also list PMLIVE Clinical Trials, which are updated daily. BioPortfolio also has a large database of PMLIVE Companies for you to search.

Showing News Articles 1–25 of 988 from PMLIVE

Tuesday 23rd January 2018

Academic-industry collaboration in the era of big data

A window on the UK

BMS' Yervoy picks up another indication in Europe

The EC licenses the immuno-oncology treatment for children with skin cancer

Monday 22nd January 2018

Glythera strengthens its scientific advisory board and appoints CSO

Dr Robert Lutz and Dr Jon Roffey join the UK biotech

Swiss biotech Inositec appoints new chief medical officer

Dr Frits van Alphen joins the group from Roche

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

French pharma firm offers $105 apiece for the spin-out’s shares

NICE finally starts review of Biogen’s Spinraza for SMA

Will evaluate the treatment based on its Single Technology Appraisal process

Amgen and Allergan win first EU approval for Avastin biosimilar

Mvasi, their version of Roche's blockbuster, is licensed for nine types of cancers

Sunday 21st January 2018

Targovax appoints Michael Bogenstaetter as chief business officer

He joins the immuno-oncology biotech from Interim Assignments

Hikma appoints group scientific officer and global head of R&D

Dr Surendera Tyagi joins the pharma group from Fresenius Kabi

Integrating digital biomarkers into precision medicine

Leveraging digital technologies to enhance the clinical evaluation and delivery of precision therapies

Friday 19th January 2018

Novartis doubles down on biosimilars with Biocon alliance

The companies will develop multiple immunology and oncology biosimilars

MHRA: No change for pre-Brexit products after UK exits the EU

And UK plans to follow EU rules for an implementation period after March 2019

AMR research 'under threat' due to lack of economic incentives

But industry report also shows progress made by the private sector

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

The bone marrow cancer therapy is now temporarily approved as a fourth-line treatment

Richard Paulson joins Ipsen as CEO for North America

He also becomes an executive vice-president at the French biopharma

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Thursday 18th January 2018

Real patient voices

The #Human behind every number project

Novartis gets speedy reviews for new Kymriah filings

US and EU regulatory agencies will review the drug for DLBCL patients

McCann Health appoints global chief digital officer

Marcus Sigurdsson is promoted from chief digital officer, Asia Pacific

Merck chalks up another win for Keytruda in lung cancer

Becomes the first PD-1 inhibitor to improve OS in NSCLC patients when combined with chemo

Wednesday 17th January 2018

Is acquisitive Celgene now eyeing CAR-T specialist Juno?

Rumours circulate just days after the US biotech confirms ImpactBio purchase

Communiqué Awards 2018 are open for entry

This year the med comms programme adds two new categories

Merck forges closer ties with Cancer Research UK

Will partake in three research projects covering hit discovery to preclinical candidate selection

Tuesday 16th January 2018

VCCP Health adds to its creative team

Sadie Mayes and Tess Evans join the agency

Perrigo appoints Gerresheimer’s Uwe Rohrhoff as CEO

He succeeds John Hendrickson, who resigns as CEO and board member

Quick Search


News Quicklinks